Trump is privately mulling how to declare pot a less dangerous drug

President Trump is actively deliberating a significant shift in federal marijuana policy, including reclassifying it from Schedule 1 to Schedule 3, a move he has privately indicated support for to industry leaders. This potential change is being pushed by political advisors as a means to attract younger voters and bolster Republican support, despite internal White House divisions and policy concerns regarding legal and moral implications. While the administration acknowledges reviewing options, the ultimate decision remains uncertain amidst mixed signals and ongoing internal debate over a policy with broad public backing and significant industry interest.

Analysis

The Trump administration is actively evaluating a significant federal policy shift to reclassify marijuana from a Schedule 1 to a Schedule 3 substance, a move that carries substantial market implications. This deliberation is driven by a conflict within the White House: political advisors advocate for the change as a strategic tool to attract younger and libertarian-leaning voters for the midterm elections, citing internal polling that frames it as an 'easy win'. Conversely, policy advisors caution against potential legal and moral ramifications, including concerns about undermining law enforcement's ability to use the scent of marijuana as probable cause. The cannabis industry is applying significant pressure, with Scotts Miracle-Gro (SMG) and Trulieve (TRUL) making substantial donations to Trump-aligned PACs and SMG's CEO claiming to have received private assurances from the President. Despite Trump's previous public support for reclassification and immense public approval—a 2024 Pew survey shows nearly 60% support recreational legalization—his personal ambivalence and the administration's inaction seven months into the term create a climate of uncertainty, leaving the high-impact decision in a state of flux.

Key Decisions for Investors

• Investors with exposure to the cannabis sector should treat potential reclassification as a primary, binary catalyst; any definitive statement from the White House could trigger significant price movement.
• Scotts Miracle-Gro (SMG) and Trulieve (TRUL) should be monitored as key bellwethers for sector sentiment, given their direct lobbying, financial contributions, and specific mentions in relation to the administration's thinking.
• It is crucial to weigh the political expediency of this policy against the noted internal White House divisions and Trump's personal history, as a failure to act would represent a major headwind for the sector.
• Monitor political developments closely, particularly polling among young voters and commentary from key influencers, as these factors appear to be primary drivers for the administration's decision-making timeline.